THE ASSOCIATION OF ENDOSCOPIC AND HISTOLOGIC ENDPOINTS WITH FAECAL CALPROTECTIN AND C-REACTIVE PROTEIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB

Remo Panaccione  1     Christophe Sapin  2     Faye Chan-Diehl     Richard Moses     Britta Siegmund  3     Alissa Walsh  4     Taku Kobayashi  5     Parambir Dulai  6     Simon Travis  7    
1 University of Calgary, Calgary, Canada
2 Eli Lilly and Company, Indianapolis, United States
3 Charit√© - Universit√§tsmedizin Berlin, Berlin, Germany
4 St Vincent's Hospital, Sydney, Australia
5 Kitasato University Kitasato Institute Hospital, Minato-ku, Japan
6 University of California San Diego, La Jolla, United States
7 John Radcliffe Hospital, Oxford, United Kingdom

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing